Successful treatment of six patients with neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure

Renal Failure

Volumn 28, Issue 1, 2006, Pages 51-55

  Sanai, Toru ^a,d   Matsui, Rei ^a   Hirano, Tadashi ^a   Torichigai, Shinichi ^a   Yotsueda, Hideki ^b   Higashi, Harumichi ^b   Hirakata, Hideki ^c   Iida, Mitsuo ^c  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b ST MARY S HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d Abe Clinic   (Japan)

Author keywords

Acute renal failure; Dantrolene sodium; Hemodiafiltration; Hemodialysis; Neuroleptic malignant syndrome; Rhabdomyolysis

Indexed keywords

ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZAMIDE; BENZISOXAZOLE; BENZODIAZEPINE; BUTYROPHENONE; DANTROLENE; HALOPERIDOL; HYPNOTIC AGENT; IMINOMIDE; NEUROLEPTIC AGENT; PHENOTHIAZINE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL ARTICLE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FEVER; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; MALE; MUSCLE RIGIDITY; MUSCLE WEAKNESS; MYOGLOBULINEMIC ACUTE RENAL FAILURE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; RHABDOMYOLYSIS; SCHIZOPHRENIA; SWEAT GLAND DISEASE; SYMPTOMATOLOGY; UREA NITROGEN BLOOD LEVEL;

ADULT; DANTROLENE; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; REMISSION INDUCTION; RENAL DIALYSIS;

EID: 32644470053     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500461252     Document Type: Article

References (22)

1. Levenson JL. Neuroleptic malignant syndrome. Am J Psych. 1985;142:1137-1145.
2. Eiser AR, Neff MS, Slifkin RF. Acute myoglobinuric renal failure - a consequence of the neuroleptic malignant syndrome. Arch Intern Med. 1982;142:601-603.
3. Greenblatt DJ, Gross PL, Harris J, Shader RI, Ciraulo DA. Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal. J Clin Psych. 1978; 38:673-675.
4. Viejo LF, Morales V, Punal P, Perez JL, Sancho RA. Risk factors in neuroleptic malignant syndrome. A case-control study. Acta Psychiatr Scand. 2003;107:45-49.
5. Shalev A, Munita H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatr Scand. 1986;73:337-347.
6. Caroff SN. The neuroleptic malignant syndrome. J Clin Psych. 1980;41:79-83.
7. Kurlan R, Hammii R, Shoulson I. Neuroleptic malignant syndrome. Clin Neuropharmacol. 1984;7:109-120.
8. Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psych. 1987;22:1004-1020.
9. Delay J, Pichot P, Lemperiere T. Un neuroleptique majeur non phenothiazinique et non reserpinique, I' haloperidol, dans le traitement des psychoses. Ann Med Psych. 1960;118:145-152.
10. Taniguchi N, Tanii H, Nishikawa T, et al. Classification system of complication in neuroleptic malignant syndrome. Meth Find Exp Clin Pharmacol. 1997;19:193-199.
11. Lev R, Clark R. Neuroleptic malignant syndrome presenting without fever: case report and review of the literature. J Emerg Med. 1994;12:49-55.
12. Soejima A, Suzuki M, Ishizuka S, et al. Clinical investigation of 10 cases with acute renal failure induced by neuroleptics. Jpn J Nephol. 1996;38:335-341 (in Japanese).
13. Kunishima Y, Masumori N, Kadono M, Tsukamoto T. A case of neuroleptic malignant syndrome in a patient with hemodialysis. Inter J Uro. 2000;7:62-64.
14. Nishimura M. Treatment of neuroleptic malignant syndrome with direct hemoperfusion. Biomat Art Cells Immnob Biotech. 1991;19:175-183.
15. Toru M, Matsuda O, Makiguchi K, Sugano K. Neuroleptic malignant syndrome-like state following a withdrawal of anti-Parkinsonian drugs. J Nerv Ment Dis. 1981;169:324-327.
16. Imaeda M, Sakai M, Misugi N, Fujiwara T. "Syndrome malin" due to neuroleptics - clinical and muscle studies of three cases. Yokohama Med Bull. 1981;32:57-69.
17. Shalev A, Hermesh H, Munita H. Mortality from neuroleptic malignant syndrome. J Clin Psych. 1989;50:18-25.
18. Levinson DF, Simpson GM. Neuroleptic-induced extrapyramidal symptoms with fever. Arch Gen Psych. 1986;43:839-848.
19. Pearlman CA. Neuroleptic malignant syndrome: a review of the literature. J Clin Psychopharmacol. 1986;6:257-273.
20. Kellam AMP. The neuroleptic malignant syndrome, so-called a survey of the world literature. Br J Psych. 1987;150:752-759.
21. Carbone JR. The neuroleptic malignant and serotonin syndromes. Emerg Med Clin of North Am. 2000;18:317-325.
22. Nishioka Y, Miyazaki M, Kub S, Ozono Y, Harada T, Kohno S. Acute renal failure in neuroleptic malignant syndrome. Renal Fail. 2002;24:539-543.